全文获取类型
收费全文 | 2064篇 |
免费 | 146篇 |
国内免费 | 11篇 |
专业分类
耳鼻咽喉 | 9篇 |
儿科学 | 140篇 |
妇产科学 | 36篇 |
基础医学 | 180篇 |
口腔科学 | 40篇 |
临床医学 | 248篇 |
内科学 | 485篇 |
皮肤病学 | 18篇 |
神经病学 | 94篇 |
特种医学 | 241篇 |
外科学 | 252篇 |
综合类 | 65篇 |
一般理论 | 1篇 |
预防医学 | 214篇 |
眼科学 | 18篇 |
药学 | 94篇 |
1篇 | |
中国医学 | 5篇 |
肿瘤学 | 80篇 |
出版年
2023年 | 6篇 |
2021年 | 27篇 |
2020年 | 18篇 |
2019年 | 25篇 |
2018年 | 35篇 |
2017年 | 25篇 |
2016年 | 25篇 |
2015年 | 44篇 |
2014年 | 51篇 |
2013年 | 61篇 |
2012年 | 88篇 |
2011年 | 89篇 |
2010年 | 76篇 |
2009年 | 78篇 |
2008年 | 82篇 |
2007年 | 76篇 |
2006年 | 75篇 |
2005年 | 64篇 |
2004年 | 64篇 |
2003年 | 52篇 |
2002年 | 57篇 |
2001年 | 45篇 |
2000年 | 61篇 |
1999年 | 42篇 |
1998年 | 94篇 |
1997年 | 98篇 |
1996年 | 95篇 |
1995年 | 62篇 |
1994年 | 54篇 |
1993年 | 47篇 |
1992年 | 32篇 |
1991年 | 36篇 |
1990年 | 26篇 |
1989年 | 52篇 |
1988年 | 44篇 |
1987年 | 48篇 |
1986年 | 29篇 |
1985年 | 34篇 |
1984年 | 39篇 |
1983年 | 28篇 |
1982年 | 23篇 |
1981年 | 22篇 |
1980年 | 11篇 |
1979年 | 7篇 |
1978年 | 10篇 |
1977年 | 9篇 |
1976年 | 9篇 |
1975年 | 9篇 |
1972年 | 6篇 |
1971年 | 7篇 |
排序方式: 共有2221条查询结果,搜索用时 15 毫秒
1.
P. A. Hannan J. A. Khan A. Khan S. Safiullah 《Indian journal of pharmaceutical sciences》2016,78(1):2-7
Dosage form is a mean used for the delivery of drug to a living body. In order to get the desired effect the drug should be delivered to its site of action at such rate and concentration to achieve the maximum therapeutic effect and minimum adverse effect. Since oral route is still widely accepted route but having a common drawback of difficulty in swallowing of tablets and capsules. Therefore a lot of research has been done on novel drug delivery systems. This review is about oral dispersible tablets a novel approach in drug delivery systems that are now a day''s more focused in formulation world, and laid a new path that, helped the patients to build their compliance level with the therapy, also reduced the cost and ease the administration especially in case of pediatrics and geriatrics. Quick absorption, rapid onset of action and reduction in drug loss properties are the basic advantages of this dosage form. 相似文献
2.
Danielle E Whittier Elizabeth J Samelson Marian T Hannan Lauren A Burt David A Hanley Emmanuel Biver Pawel Szulc Elisabeth Sornay-Rendu Blandine Merle Roland Chapurlat Eric Lespessailles Andy Kin On Wong David Goltzman Sundeep Khosla Serge Ferrari Mary L Bouxsein Douglas P Kiel Steven K Boyd 《Journal of bone and mineral research》2022,37(3):428-439
Prevalence of osteoporosis is more than 50% in older adults, yet current clinical methods for diagnosis that rely on areal bone mineral density (aBMD) fail to detect most individuals who have a fragility fracture. Bone fragility can manifest in different forms, and a “one-size-fits-all” approach to diagnosis and management of osteoporosis may not be suitable. High-resolution peripheral quantitative computed tomography (HR-pQCT) provides additive information by capturing information about volumetric density and microarchitecture, but interpretation is challenging because of the complex interactions between the numerous properties measured. In this study, we propose that there are common combinations of bone properties, referred to as phenotypes, that are predisposed to different levels of fracture risk. Using HR-pQCT data from a multinational cohort (n = 5873, 71% female) between 40 and 96 years of age, we employed fuzzy c-means clustering, an unsupervised machine-learning method, to identify phenotypes of bone microarchitecture. Three clusters were identified, and using partial correlation analysis of HR-pQCT parameters, we characterized the clusters as low density, low volume, and healthy bone phenotypes. Most males were associated with the healthy bone phenotype, whereas females were more often associated with the low volume or low density bone phenotypes. Each phenotype had a significantly different cumulative hazard of major osteoporotic fracture (MOF) and of any incident osteoporotic fracture (p < 0.05). After adjustment for covariates (cohort, sex, and age), the low density followed by the low volume phenotype had the highest association with MOF (hazard ratio = 2.96 and 2.35, respectively), and significant associations were maintained when additionally adjusted for femoral neck aBMD (hazard ratio = 1.69 and 1.90, respectively). Further, within each phenotype, different imaging biomarkers of fracture were identified. These findings suggest that osteoporotic fracture risk is associated with bone phenotypes that capture key features of bone deterioration that are not distinguishable by aBMD. © 2021 American Society for Bone and Mineral Research (ASBMR). 相似文献
3.
PJ Commerford 《Cardiovascular journal of Africa》2015,26(4):151-Aug;26(4):151
4.
Hans Bosma Martin PJ van Boxtel Gertrudis IJM Kempen Jacques ThM van Eijk Jelle Jolles 《BMC public health》2007,7(1):179
Background
The aims of this study were to examine the extent to which higher intellectual abilities protect higher socio-economic groups from functional decline and to examine whether the contribution of intellectual abilities is independent of childhood deprivation and low birth weight and other socio-economic and developmental factors in early life. 相似文献5.
6.
7.
8.
9.
Previous reports in the literature have described correlation of increasing repeat length with severity of the phenotype, in Kennedy syndrome. We describe male siblings with different repeat lengths, with lack of expression of the phenotype in the sibling with the longer repeat length. The phenotype was identical to motor neurone disease. There is variability of expression in Kennedy syndrome and repeat length even in siblings cannot be taken as a conclusive indicator of severity. CAG repeat length cannot be used to predict the natural history of Kennedy disease. The diagnosis of Kennedy syndrome should be considered in male patients presenting with atypical motor neurone disease. 相似文献
10.
PJ Woll PhD MRCP R Pettengell PhD FRACP 《International journal of clinical practice》1997,51(2):111-115
SUMMARY The interferons are natural glycoproteins secreted in response to various stimuli, including viral infection. They have antiviral, antiproliferative and immunomodulatory effects on different target cell populations. Since recombinant human interferons have become available, they have been tested in a wide range of malignancies. They are well established in the treatment of hairy cell leukaemia, chronic myelogenous leukaemia and multiple myeloma. Although they have documented activity against lymphoma, melanoma, renal cell cancer and carcinoid tumours, their role in the treatment of these tumours is less clear. In the common solid tumours, such as lung cancer and colorectal cancer, the use of interferons remains experimental. Here we will summarise their practice applications in oncology, using randomised studies where available to establish their place in multi-modality treatment. We will not discuss their use as antiviral or immunomodulating agents in viral and autoimmune diseases, multiple sclerosis or after organ transplantation. 相似文献